112 related articles for article (PubMed ID: 1638538)
1. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A.
Serrero G; Lepak NM; Hayashi J; Eisinger DP
Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538
[TBL] [Abstract][Full Text] [Related]
2. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
Serrero G; Zhou J; Mills D; LePak N
J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
[TBL] [Abstract][Full Text] [Related]
3. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
4. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
5. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
Minke JM; Schuuring E; van den Berghe R; Stolwijk JA; Boonstra J; Cornelisse C; Hilkens J; Misdorp W
Cancer Res; 1991 Aug; 51(15):4028-37. PubMed ID: 1649697
[TBL] [Abstract][Full Text] [Related]
6. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
Mawatari M; Kohno K; Mizoguchi H; Matsuda T; Asoh K; Van Damme J; Welgus HG; Kuwano M
J Immunol; 1989 Sep; 143(5):1619-27. PubMed ID: 2547871
[TBL] [Abstract][Full Text] [Related]
7. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
11. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor.
Dong XF; Berthois Y; Martin PM
Anticancer Res; 1991; 11(2):737-43. PubMed ID: 2064328
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.
Gruber HE; Hoelscher G; Loeffler B; Chow Y; Ingram JA; Halligan W; Hanley EN
Spine J; 2009 Sep; 9(9):760-6. PubMed ID: 19535298
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
16. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.
Fayed YM; Tsibris JC; Langenberg PW; Robertson AL
Lab Invest; 1989 Jan; 60(1):30-7. PubMed ID: 2536127
[TBL] [Abstract][Full Text] [Related]
17. Identification of insulin receptors on the insulin-independent variant 1246-3A cell line.
Gazzano H; Serrero G
J Cell Physiol; 1988 Aug; 136(2):348-54. PubMed ID: 3045134
[TBL] [Abstract][Full Text] [Related]
18. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
19. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
Pietenpol JA; Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
Fish EN; Ghislain J; Trogadis J; Stevens JK
Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
